Dong-Hoon Won

Title: Dong-Hoon Won: Innovator in Photopyrin Compounds

Introduction

Dong-Hoon Won is a notable inventor based in Wonju, South Korea. He has made significant contributions to the field of photodynamic therapy through his innovative research and development of novel photopyrin compounds. His work focuses on creating effective agents for cancer treatment, showcasing his commitment to advancing medical science.

Latest Patents

Dong-Hoon Won holds a patent for "Porphyrin derivatives." This invention relates to novel photopyrin compounds and their pharmaceutically acceptable salts, which are useful as anticancer or photodynamic diagnostic agents. The inventive compounds are designed to reproduce singlet state oxygen radicals, offering superior advantages such as excellent photon yield for producing singlet oxygen, good physical stability, and potent cell cytotoxicity compared to conventional photosensitizers. The patent also includes a pharmaceutical composition comprising a novel photopyrin compound as an active ingredient for preventing or treating various cancers, including stomach cancer, liver cancer, lung cancer, cervical cancer, and breast cancer in humans or mammals.

Career Highlights

Dong-Hoon Won is associated with Kostarworld Co., Ltd., where he continues to innovate and develop new solutions in the field of photodynamic therapy. His dedication to research and development has positioned him as a key figure in the advancement of cancer treatment technologies.

Collaborations

He has collaborated with notable colleagues, including Nam-Tae Woo and Min-Suk Kang, to further enhance the impact of his research and innovations in the medical field.

Conclusion

Dong-Hoon Won's contributions to the development of photopyrin compounds represent a significant advancement in cancer treatment. His innovative approach and dedication to research continue to inspire progress in the medical community.